1. Home
  2. SILO vs BSLK Comparison

SILO vs BSLK Comparison

Compare SILO & BSLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SILO
  • BSLK
  • Stock Information
  • Founded
  • SILO 2010
  • BSLK 2009
  • Country
  • SILO United States
  • BSLK United States
  • Employees
  • SILO N/A
  • BSLK N/A
  • Industry
  • SILO Apparel
  • BSLK
  • Sector
  • SILO Consumer Discretionary
  • BSLK
  • Exchange
  • SILO Nasdaq
  • BSLK NYSE
  • Market Cap
  • SILO 8.8M
  • BSLK 10.3M
  • IPO Year
  • SILO N/A
  • BSLK N/A
  • Fundamental
  • Price
  • SILO $1.35
  • BSLK $0.47
  • Analyst Decision
  • SILO
  • BSLK
  • Analyst Count
  • SILO 0
  • BSLK 0
  • Target Price
  • SILO N/A
  • BSLK N/A
  • AVG Volume (30 Days)
  • SILO 228.4K
  • BSLK 17.2M
  • Earning Date
  • SILO 03-04-2025
  • BSLK 03-07-2025
  • Dividend Yield
  • SILO N/A
  • BSLK N/A
  • EPS Growth
  • SILO N/A
  • BSLK N/A
  • EPS
  • SILO N/A
  • BSLK N/A
  • Revenue
  • SILO $72,102.00
  • BSLK $1,489,000.00
  • Revenue This Year
  • SILO $1.86
  • BSLK N/A
  • Revenue Next Year
  • SILO N/A
  • BSLK N/A
  • P/E Ratio
  • SILO N/A
  • BSLK $0.11
  • Revenue Growth
  • SILO N/A
  • BSLK N/A
  • 52 Week Low
  • SILO $0.77
  • BSLK $0.23
  • 52 Week High
  • SILO $4.50
  • BSLK $17.02
  • Technical
  • Relative Strength Index (RSI)
  • SILO 40.14
  • BSLK N/A
  • Support Level
  • SILO $1.39
  • BSLK N/A
  • Resistance Level
  • SILO $1.52
  • BSLK N/A
  • Average True Range (ATR)
  • SILO 0.14
  • BSLK 0.00
  • MACD
  • SILO -0.05
  • BSLK 0.00
  • Stochastic Oscillator
  • SILO 0.97
  • BSLK 0.00

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

About BSLK BOLT PROJECTS HOLDINGS INC

Bolt Projects Holdings Inc formerly Golden Arrow Merger Corp is an shell company.

Share on Social Networks: